James P Flynn is of MEI Pharma, Inc.. Currently has a direct ownership of 100,000 shares of MEIP, which is worth approximately $260,000. The most recent transaction as insider was on Dec 19, 2025, when has been sold 70,000 shares (Common Stock) at a price of $1.4 per share, resulting in proceeds of $98,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
458.66% 3M change
1165.82% 12M change
Total Value Held $260,000

James P Flynn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2025
BUY
Open market or private purchase
$98,000 $1.4 p/Share
70,000 Added 41.18%
100,000 Common Stock
Nov 19 2025
BUY
Open market or private purchase
$22,748 $1.88 p/Share
12,100 Added 28.74%
30,000 Common Stock
Sep 30 2025
BUY
Grant, award, or other acquisition
$25,400 $2.54 p/Share
10,000 Added 35.84%
17,900 Common Stock
May 16 2024
BUY
Grant, award, or other acquisition
$24,964 $3.16 p/Share
7,900 Added 50.0%
7,900 Common Stock

Also insider at

ABIO
ARCA biopharma, Inc. Healthcare
SYBX
SYNLOGIC, INC. Healthcare
JPF

James P Flynn

Westminster, CO

Track Institutional and Insider Activities on MEIP

Follow MEI Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MEIP shares.

Notify only if

Insider Trading

Get notified when an Mei Pharma, Inc. insider buys or sells MEIP shares.

Notify only if

News

Receive news related to MEI Pharma, Inc.

Track Activities on MEIP